Novavax (NVAX), European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine

Go back to Novavax (NVAX), European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine
Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.41 +0.30 (2.97%)
Previous Close $10.11    52 Week High $9.23 
Open $10.38    52 Week Low $1.16 
Day High $10.70    P/E N/A 
Day Low $10.21    EPS $-0.30 
Volume 6,135,225